Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study
PHASE2
This phase II trial studies whether adding radium-223 dichloride to the usu...
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
PHASE2
This phase II/III trial studies how well radiation therapy works when given...
Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant
PHASE2
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
PHASE2
This study is being done to answer the following questions:
Can we lower t...
Status
Recruiting
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care